Home›Stock Screener›Nureca›Financial Statements

Nureca Complete Financial Statements

8 Years of Data
2026 - 2019

In FY2026, Nureca (NURECA) reported revenue ₹36 Cr, net profit ₹-6 Cr and EPS ₹-6.45, with a net profit margin of -16.7% and ROE of -3.1%. Full financial statements from FY2019 to FY2026 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Nureca ownership structure to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -16.67% 2026 data
EBITDA Margin -13.89% 2026 data
Operating Margin -16.00% 2026 data
Return on Assets -2.86% 2026 data
Return on Equity -3.09% 2026 data

Balance Sheet Ratios

Current Ratio 63.33 2026 data
Equity Ratio 92.38% 2026 data
Asset Turnover 0.17 2026 data

NURECA Revenue, Net Profit & EBITDA — Year-on-Year Growth

NURECA YoY (Mar 2025 vs Mar 2026) — revenue +5.9%, net profit -300.0%, EBITDA -266.7%, expenses +32.3%. Examine NURECA earnings for recent quarterly revenue, profit and EPS trends.

Revenue Growth
+5.9%
Year-over-Year
Net Profit Growth
-300.0%
Year-over-Year
EBITDA Growth
-266.7%
Year-over-Year
Expense Growth
+32.3%
Year-over-Year
Assets Growth
+2.4%
Year-over-Year
Equity Growth
+0.5%
Year-over-Year
Operating Cash Flow Growth
-533.3%
Year-over-Year
Investing Cash Flow Growth
-55.6%
Year-over-Year
Financing Cash Flow Growth
+100.0%
Year-over-Year

NURECA Income Statement — Revenue, EBITDA & Net Profit

Nureca revenue ₹36 Cr, EBITDA ₹-5 Cr, net profit ₹-6 Cr, EPS ₹-6.45 (2026) — net profit margin -16.7%. For live price, earnings ratios and company overview, see NURECA stock price BSE.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020
Revenue 36 40 34 37 42 34 16 26 28 35 23 24 28 39 43 27 30 49 33 122 50 93 33 30 60
Expenses 41 35 31 35 36 34 21 23 31 30 25 24 27 42 44 31 29 41 28 72 43 56 29 17 52
EBITDA -5 6 3 2 5 1 -6 3 -3 5 -1 0 2 -3 -1 -5 1 8 6 49 7 37 4 13 9
Operating Profit Margin % -16.00% 9.00% 4.00% -2.00% 8.00% -8.00% -26.00% -12.00% -15.00% 4.00% -16.00% -14.00% -19.00% -13.00% -7.00% -22.00% -3.00% 13.00% 14.00% 39.00% 11.00% 39.00% 11.00% 43.00% 13.00%
Depreciation 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0
Interest 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Profit Before Tax -6 5 2 1 5 0 -7 3 -3 4 -2 -1 1 -4 -2 -5 0 8 5 49 6 36 3 13 9
Tax 1 1 0 0 1 0 -2 1 -1 1 0 0 1 -1 -1 -1 0 2 1 13 2 9 1 3 2
Net Profit -6 4 3 1 4 -1 -4 2 -3 3 -2 -1 0 -3 -1 -4 0 5 4 36 5 27 2 9 6
Earnings Per Share (₹) -6.45 3.63 2.47 0.81 3.91 -0.48 -4.15 1.66 -2.80 2.90 -1.53 -0.71 0.16 -2.89 -1.40 -4.13 0.30 5.43 4.56 36.20 4.73 38.19 3.40 13.50 8.53

NURECA Balance Sheet — Assets, Liabilities & Shareholders' Equity

NURECA total assets ₹210 Cr, total equity ₹194 Cr, total liabilities ₹ Cr (2025) — ROE -3.1%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019
ASSETS
Total Assets 210 205 207 219 186 34 24
Current Assets 190 193 187 206 181 33 23
Fixed Assets 9 7 9 10 4 1 1
Capital Work in Progress 0 0 0 0 0 0 0
Investments 1 94 59 33 0 0 0
Other Assets 200 104 139 175 182 33 23
LIABILITIES
Total Liabilities
Current Liabilities 3 3 3 4 4 9 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 194 193 195 203 163 15 8
Share Capital 10 10 10 10 10 0 0
Reserves & Surplus 184 183 185 193 153 15 8

NURECA Cash Flow Statement — Operating, Investing & Financing

Nureca operating cash flow ₹-19 Cr, investing ₹8 Cr, financing ₹0 Cr, net cash flow ₹-11 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019
Operating Activities -19 -3 10 1 35 -8 0
Investing Activities 8 18 -17 -3 -110 0 0
Financing Activities 0 -1 -2 -7 92 8 0
Net Cash Flow -11 14 -8 -9 17 0 0